Technical analysis of Keros Therapeutics, Inc. (KROS): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
Keros Therapeutics, Inc., a biopharmaceutical entity in the clinical development phase, is focused on pioneering and commercializing innovative therapies for individuals afflicted by hematological and musculoskeletal conditions that currently lack adequate treatment options.
Price Performance
| 1 month | +1.23% |
| 3 months | +0.85% |
| Year-to-date | -47.25% |
| 1 year | -31.24% |
| 3 years | -69.76% |
| 5 years | -65.05% |
52-Week Range
| 52-week High | $22.55 |
| 52-week Low | $9.69 |
| Avg Volume (90d) | 257K |
Technical Indicators
| SMA 50 | $10.81 |
| SMA 200 | $13.44 |
| Beta | 0.99 |
| 30-day Volatility (annualised) | 52.7% |
| Price vs SMA 50 | -0.7% |
| Price vs SMA 200 | -20.1% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-10 | $15.22 | |
| 2025-11 | $17.48 | +14.8% |
| 2025-12 | $20.36 | +16.5% |
| 2026-01 | $17.91 | -12.0% |
| 2026-02 | $14.19 | -20.8% |
| 2026-03 | $11.04 | -22.2% |
| 2026-04 | $11.12 | +0.7% |
| 2026-05 | $11.25 | +1.2% |
| 2026-06 | $10.70 | -4.9% |
| 2026-07 | $10.07 | -5.9% |
| 2026-08 | $11.08 | +10.0% |
| 2026-09 | $10.74 | -3.1% |
Price
| Price | $10.74 |
| Market Cap | $344M |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| Price / Book | 0.81 |
| EV / EBITDA | -1.38 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | 0.06 |
| Current Ratio | 21.96 |